Juniper Research's “Remote Patient Monitoring” report provides a detailed evaluation of the market, including the adoption of remote patient monitoring within both developing markets and established markets. In addition, this report covers market opportunities; providing strategic insights into the technologies and key drivers that are pushing the space forward. This report analyses the role of 15 leading remote patient monitoring vendors across the market, evaluating them through a competitor leaderboard.
The research suite also contains a detailed dataset; providing forecasts for 60 countries across a number of different metrics, including the number of remote patient monitoring patients, number of remote patient monitoring devices split by device type, including ECG (Electrocardiogram), blood pressure INR (International Normalised Ratio) test, pulse oximeter, glucose monitor, Bluetooth scale and smartwatches, total spend on remote patient monitoring hardware and software and total remote patient monitoring revenue.
Key Market Statistics
|Market size in 2023:||$72bn
|Market size in 2027:||$110bn
|2023 to 2027 growth:||54%
This research suite comprises of:
- Market Trends & Strategies (PDF)
- Competitor Leaderboard (PDF)
- Data & Forecasts (PDF & Excel)
- 12 Months' Access to harvest Online Data Platform
- Market Dynamics: A strategic analysis of the major drivers, challenges, and innovations shaping the adoption and development of remote patient monitoring, including the following:
- COVID-19's impact on the remote patient monitoring market.
- Future strategic direction and market outlook for remote patient monitoring.
- Key drivers for remote patient monitoring vendors, including nurse shortages and healthcare system struggles.
- Regional Analysis: A regional-level analysis of 16 countries, spanning 8 key regions; covering the current deployment level and future outlook of remote patient monitoring. Giving readers insight into the markets with the best opportunities for remote patient monitoring.
- Benchmark Industry Forecasts: Includes forecasts for the total number of remote patient monitoring patients, number of remote patient monitoring devices, total spend on remote patient monitoring hardware and software and total remote patient monitoring revenue. This data is split by device type and our 8 key forecast regions and 60 countries:
- Latin America:
- Argentina, Brazil, Chile, Colombia, Ecuador, Mexico, Peru, Uruguay
- West Europe:
- Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, UK
- Central & East Europe:
- Croatia, Czech Republic, Hungary, Poland, Romania, Russia, Turkey, Ukraine
- Far East & China:
- China, Hong Kong, Japan, South Korea
- Indian Subcontinent:
- Bangladesh, India, Nepal, Pakistan
- Rest of Asia Pacific:
- Australia, Indonesia, Malaysia, New Zealand, Philippines, Singapore, Thailand, Vietnam
- Africa & Middle East:
- Algeria, Egypt, Israel, Kenya, Kuwait, Nigeria, Qatar, Saudi Arabia, South Africa, United Arab Emirates
- Juniper Research Competitor Leaderboard: Key player capability and capacity assessment for 15 remote patient monitoring vendors:
- Abbott Laboratories
- AMC Health
- Boston Scientific Corporation
- GE Healthcare
- Omron Corporation
- Orion Health
KEY QUESTIONS ANSWERED
- 1. How will key market trends affect projected remote patient monitoring adoption?
- 2. What technologies will accelerate remote patient monitoring?
- 3. Who are the leading vendors in the remote patient monitoring market?
- 4. What limitations are there holding back remote patient monitoring?
- 5. What regions will remote patient monitoring be most successful in?
- Included in Juniper Research Competitor Leaderboard: Abbott Laboratories, AMC Health, Biotronik, Boston Scientific, Dräger, GE HealthCare, Masimo, MedM, Medtronic, Omron Corporation, Orion Health, Philips, Qure4u, Roche, Vivalink.
- Mentioned: Acutronic, AFVD, AliveCor, Ascom, AWS, BiolntelliSense, Bionet, Bow Medical, Brainlab, Community Wellness, Doctor Anywhere, Dystonia Europe, EPDA, Luscii, Mazzetti, Partners HealthCare, Phoenix, Qualcomm, Samsung, Triton, University Hospitals, Verustat.
DATA & INTERACTIVE FORECAST
Key Market Forecast Splits
- Device Type:
- Blood Pressure INR Test
- Pulse Oximeter
- Glucose Monitor
- Bluetooth Scale
Metrics include the number of users leveraging remote patient monitoring, the number of devices in use for remote patient monitoring, total spend on remote patient monitoring software and hardware and total remote patient monitoring revenue.
- Geographical splits: 60 countries
- Number of tables: Over 205 tables
- Number of datapoints: Over 140,000 datapoints
harvest: Our online data platform, harvest, contains the very latest market data and is updated throughout the year. This is a fully featured platform enabling clients to better understand key data trends and manipulate charts and tables; overlaying different forecasts within the one chart - using the comparison tool. Empower your business with our market intelligence centre, and receive alerts whenever your data is updated.
Interactive Excels (IFxl): Our IFxl tool enables clients to manipulate both forecast data and charts, within an Excel environment, to test their own assumptions using the interactive scenario tool and compare selected markets side by side in customised charts and tables. IFxls greatly increase a client's ability to both understand a particular market and to integrate their own views into the model.
The total number of patients using RPM solutions will reach 115.5 million globally by 2027; equating to 1.4% of the total population. This is an increase from only 75 million in 2023. This growth of 67% is driven by greater pressure on healthcare systems, including clinical staff shortages and limited space within hospitals, driving the need for alternative healthcare solutions. RPM enables care to be moved outside of overstressed healthcare facilities; boosting healthcare providers' efficiency.
- By 2027, there will be 90 million cardiac patients using RPM solutions. Given the high global prevalence of cardiac conditions, the report recommended that healthcare providers use RPM solutions to monitor the heart rate and blood pressure of cardiac patients at home to lower the number of patients in hospital. RPM solutions will also indirectly decrease disease transmission rates and alleviate pressure on healthcare systems by reducing the demand for hospital beds.
- Healthcare service providers should fully leverage the data generated by the increase in adoption of RPM devices. To maximise the benefits, it recommended that RPM services fully incorporate AI within their solutions to enable healthcare professionals to improve the efficiency of medical triage processes through a predictive proactive healthcare provision model.